{"id":1662,"date":"2021-10-15T00:00:09","date_gmt":"2021-10-14T22:00:09","guid":{"rendered":"https:\/\/demoucelle.sites-stag.agency\/uncategorized\/the-demoucelle-parkinson-charity-invests-in-stem-cell-therapy-research-project\/"},"modified":"2026-08-23T02:18:31","modified_gmt":"2026-08-23T00:18:31","slug":"the-demoucelle-parkinson-charity-invests-in-stem-cell-therapy-research-project","status":"publish","type":"post","link":"https:\/\/demoucelle.sites-stag.agency\/fr\/research\/dpc-supported-research\/the-demoucelle-parkinson-charity-invests-in-stem-cell-therapy-research-project\/","title":{"rendered":"Le Demoucelle Parkinson Charity investit dans un projet de recherche sur la th\u00e9rapie par cellules souches"},"content":{"rendered":"<pre class=\"wp-block-verse\"><mark style=\"background-color:#abb8c3\" class=\"has-inline-color\">Cet article a \u00e9t\u00e9 traduit \u00e0 l'aide de Deepl. Nous vous prions de bien vouloir nous excuser pour les \u00e9ventuelles erreurs ou formulations \u00e9tranges.<\/mark><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">The Demoucelle Parkinson Charity has decided to support human trials of a stem cell therapy that it is hoped can significantly slow, or even, stop Parkinson\u2019s disease. The charity\u2019s investment committee met in September and decided to provide a grant to this US-based research project, which is also supported by The Michael J. Fox Foundation for Parkinson\u2019s Research.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pour plus d'informations sur cette \u00e9tude, veuillez cliquer sur ce lien ou lire le texte ci-dessous.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.michaeljfox.org\/grant\/phase-ii-trial-bone-marrow-derived-mesenchymal-stem-cells-disease-modifying-therapy\" target=\"_blank\" rel=\"noopener\">https:\/\/www.michaeljfox.org\/grant\/phase-ii-trial-bone-marrow-derived-mesenchymal-stem-cells-disease-modifying-therapy<\/a><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>&nbsp;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Phase II Trial of Bone Marrow-Derived Mesenchymal Stem Cells as a Disease-Modifying Therapy for Parkinson\u2019s Disease.<\/strong><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Justification de l'\u00e9tude :&nbsp;<\/strong><\/em><br><em>Chronic brain inflammation plays a critical role in the development and progression of Parkinson\u2019s disease. This inflammation damages the brain, disrupts the blood-brain barrier, and creates a pro-inflammatory condition. Mesenchymal stem cells can modulate immune response and&nbsp;are capable of migrating to sites of injury. Such stem cells&nbsp;are able to recognize and react to the environment by secreting several molecules, including anti-inflammatory molecules and growth factors that interact with the surrounding cells, that can allow damaged brain&nbsp;cells to regenerate.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Hypoth\u00e8se :<\/strong><\/em><br><em>Our hypothesis is that multiple intravenous infusions of mesenchymal stem cells from the bone marrow of a healthy donor will significantly slow the progression of Parkinson\u2019s disease when compared to placebo over a year.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Conception de l'\u00e9tude :<\/strong><\/em><br><em>We aim to recruit 45 patients with early to moderate Parkinson\u2019s disease and assign them to one of three treatment arms. Group one will receive 3 infusions of placebo every 3 months; group two will receive 2 infusions of 10 X 10<sup>6<\/sup>&nbsp;MSC\/Kg every 3 months and 1 placebo infusion; and group three will receive&nbsp;3 infusions of 10 X 10<sup>6<\/sup>&nbsp;MSC\/Kg every 3 months. All subjects will receive 3 infusions, with 3 months intervals in between. They will be monitored for adverse reactions and clinical improvement for a year after the last infusion.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Impact on Diagnosis\/Treatment of Parkinson\u2019s Disease:<\/strong><\/em><br><em>Cell-based therapy has the potential to be&nbsp;a transformative approach in the treatment of Parkinson\u2019s disease. By ending the destructive inflammatory process, mesenchymal stem cells may re-establish an equilibrium that promotes cell regeneration.&nbsp;This could slow or stop the disease process and restore health to the brain.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Prochaines \u00e9tapes de d\u00e9veloppement :<\/strong><\/em><br><em>This&nbsp;trial intends to provide evidence on the safety, effectiveness, and mechanism of action of&nbsp;multiple infusions of mesenchymal stem cells as a treatment&nbsp;to change the progression of Parkinson\u2019s disease. If results are positive, the investigators expect to progress to a large multi-site clinical trial to identify the most effective number of interventions.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Researchers<\/strong><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Mya Caryn Schiess, MD<\/em><br><em>Houston, TX United States<\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">Photo by <a href=\"https:\/\/unsplash.com\/@f7photo?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText\" target=\"_blank\" rel=\"noopener\">Michael Longmire<\/a> sur <a href=\"https:\/\/unsplash.com\/s\/photos\/science?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText\" target=\"_blank\" rel=\"noopener\">Unsplash<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>En savoir plus sur le 14e projet soutenu par le DPC<\/p>","protected":false},"author":1,"featured_media":3671,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[],"class_list":["post-1662","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dpc-supported-research"],"_links":{"self":[{"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/posts\/1662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/comments?post=1662"}],"version-history":[{"count":4,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/posts\/1662\/revisions"}],"predecessor-version":[{"id":4140,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/posts\/1662\/revisions\/4140"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/media\/3671"}],"wp:attachment":[{"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/media?parent=1662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/categories?post=1662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demoucelle.sites-stag.agency\/fr\/wp-json\/wp\/v2\/tags?post=1662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}